Health & Medicine
FDA Approves Farxiga for Diabetes Type-2
The U.S Food and Drug Administration has approved AstraZeneca drug Farxiga (dapaglifozin) to improve glucose control in people suffering from diabetes. The drug is to be used along with diet and exercise, the agency said Wednesday.
Latest Research Articles
Ontario Women Continue to Outlive Men as Number of Centenarians Grows
Cancer Death Rates Decline by 20 Percent Over Last 20 Years
Valproate Can give 'Perfect Pitch'
8 Million Lives Saved Since Historic Anti-Smoking Report Released
Breastfeeding May Lower a Woman's Risk of Rheumatoid Arthritis
Mediterranean Diet linked with Low Diabetes Type-2 Risk
Mindfulness Meditation may Lower Anxiety, Depression: Study
Car Exhaust, Grilling Generate Mutagenic Compounds Previously Unknown to Science
Fear of Childbirth Increases Risk of Postpartum Depression, Study Suggests
Concussion Recovery Aided by Mental Rest
Global Health Crisis Could be Averted by Imposing Fee on Non-Human Antibiotic Use: Study
Widespread Flu Reported in 25 States: CDC
MOST POPULAR
-
Volcano Alert: Closely Monitoring Magma Movements to Predict Big Eruptions
-
How Many Seconds Does Earthquake Early Warning Really Buy?
-
Coral Bleaching Crisis: Ocean Heatwaves Devastate Reefs and Marine Biodiversity
-
Insect Decline Exposed: Biodiversity Loss, Ecosystem Chaos, and Human Peril Ahead
-
Carbon Capture Technologies: Effective CO2 Reduction Tool or Overhyped Climate Fix?
